Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum/glucocorticoid-regulated kinase 1 regulates vascular inflammation in atherosclerosis.

Acta pharmacologica Sinica·2026
Same author

Stratifying prognosis in heart failure patients with reduced ejection fraction and atrial cardiomyopathy.

ESC heart failure·2026
Same author

METTL14 inhibits atherogenesis by epigenetically activating PPAR-α/γ transcription and fatty acid oxidation in VSMCs.

Cardiovascular research·2026
Same author

Parsimonious echocardiography-based model for predicting long-term all-cause mortality in heart failure with preserved ejection fraction.

Heart (British Cardiac Society)·2026
Same author

Sirtuin 1 is an endogenous NETosis inhibitor that becomes dysfunctional in diabetes.

Journal of leukocyte biology·2026
Same author

Loss of Fsr quorum sensing promotes biofilm formation and worsens outcomes in enterococcal infective endocarditis.

Nature communications·2026

Related Experiment Video

Updated: Jun 13, 2026

Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion
08:22

Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion

Published on: March 20, 2017

Endothelial dysfunction: the common consequence in diabetes and hypertension.

Wing Tak Wong1, Siu Ling Wong, Xiao Yu Tian

  • 1Institute of Vascular Medicine, Li Ka Shing Institute of Health Sciences, and School of Biomedical Sciences, Chinese University of Hong Kong, Shatin, NT, Hong Kong SAR, China.

Journal of Cardiovascular Pharmacology
|April 28, 2010
PubMed
Summary

Endothelial dysfunction in diabetes and hypertension causes vascular damage. Therapies targeting reactive oxygen species and the renin-angiotensin system may reverse this dysfunction, reducing cardiovascular risks.

More Related Videos

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
06:35

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Published on: April 27, 2016

Related Experiment Videos

Last Updated: Jun 13, 2026

Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion
08:22

Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion

Published on: March 20, 2017

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
06:35

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Published on: April 27, 2016

Area of Science:

  • Cardiovascular Science
  • Endocrinology
  • Nephrology

Background:

  • Endothelial dysfunction is a critical early event in vascular complications associated with diabetes and hypertension.
  • It involves reduced production of protective factors like nitric oxide and increased production of vasoconstrictors (e.g., angiotensin II) and inflammatory mediators.
  • This imbalance leads to increased vascular tone, remodeling, and damage to microvascular, macrovascular, and renal systems.

Purpose of the Study:

  • To elucidate the mechanisms of endothelial dysfunction in diabetes and hypertension.
  • To explore potential therapeutic strategies for reversing endothelial dysfunction and mitigating associated vascular damage.

Main Methods:

  • The study reviews the pathophysiology of endothelial dysfunction.
  • It discusses the roles of nitric oxide, angiotensin II, endothelin-1, reactive oxygen species, and cyclooxygenase metabolites.
  • It examines the potential of targeted therapies.

Main Results:

  • Endothelial dysfunction is characterized by an imbalance between vasoprotective and vasoconstrictive factors.
  • This dysfunction contributes significantly to hypertension, vascular remodeling, and end-organ damage.
  • Therapeutic interventions targeting reactive oxygen species and the renin-angiotensin system show promise.

Conclusions:

  • Reversing endothelial dysfunction is crucial for managing cardiovascular morbidity and mortality in patients with diabetes and hypertension.
  • Targeting reactive oxygen species and the renin-angiotensin system are promising therapeutic avenues.
  • Enhancing endothelial nitric oxide synthase activity may also prove beneficial.